<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04363112</url>
  </required_header>
  <id_info>
    <org_study_id>29BRC20.0056</org_study_id>
    <nct_id>NCT04363112</nct_id>
  </id_info>
  <brief_title>Association Between a Biological Pattern of Dysregulation of the HPA Axis and Mental Disorders in Children Exposed to Early Life Stress</brief_title>
  <acronym>ESASP</acronym>
  <official_title>Association Between a Biological Pattern of Dysregulation of the HPA Axis and Mental Disorders in Children Exposed to Early Life Stress</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to demonstrate an association between a biological pattern of
      dysregulation of the HPA axis and mental disorders in children exposed to early life stress.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to demonstrate an association between a biological pattern of
      dysregulation of the HPA axis and mental disorders in children exposed to early life stress.

      Cortisol secretion lead to define two groups : pathologic versus normal cortisol secretion.

      Mental disorders is evaluate with Mini-Kids II (a mental health questionary) and lead to
      define two groups : mental disorders versus no mental disorders
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The study is an monocentric, interventional, comparative uncontrolled study</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mini Kid II : Mini International Neuropsychiatric Interview</measure>
    <time_frame>Day 3 to the study</time_frame>
    <description>Standardized questionary administered by a physician. There are 30 pages with 17 subjects like depression, maniac trouble, panic trouble, etc.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Score CBCL score : Child Behaviour Check List</measure>
    <time_frame>Day 3 to the study</time_frame>
    <description>CBCL Score is a hetero scale administered by host family or caseworker between day 3 and 7 to the study. It is a scale 0 (no behavior troubles) to 124 (behavior troubles).</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">38</enrollment>
  <condition>Mental Disorder, Child</condition>
  <arm_group>
    <arm_group_label>study with just one arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All of participants are in this arm. Mini Kid II and CBCL score are administered between day 3 and 7. Moreover, salivary test will be remove to evaluate cortisol secretion, 4 time per day during 2 consecutive days.
Psychologic aftercare will be propose if children have psychologic troubles (results of Mini Kid II)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mini Kid II</intervention_name>
    <description>Mini Kid II (Mini International Neuropsychiatric Interview ) is a standardised, hetero mental health questionary for children, according to DSM IV. Mini Kid II will be administered to children between day 3 and 7 during the study.</description>
    <arm_group_label>study with just one arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 8 to over 10 years

          -  To be entrust to ASE of Finist√®re in stable environment (the same place of residence
             since 6 months or more)

          -  French speaking

          -  Oral consent by children

          -  Informed and signed consent by tenured of parent authority

        Exclusion Criteria:

          -  Don't want to participate

          -  To have chronic neurologic or endocrinal pathology or don't have access to verbal
             language.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Guillaume BRONSARD, Pr</last_name>
    <phone>06 17 99 88 65</phone>
    <email>guillaume.bronsard@chu-brest.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierre-Antoine LEROUX</last_name>
    <phone>06 40 25 55 65</phone>
    <email>pierreantoine-leroux@live.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHRU de Brest</name>
      <address>
        <city>Brest Cedex</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Guillaume BRONSARD, Pr</last_name>
      <phone>06 17 99 88 65</phone>
      <email>guillaume.bronsard@chu-brest.fr</email>
    </contact>
    <contact_backup>
      <last_name>Pierre-Antoine LEROUX</last_name>
      <phone>06 40 25 55 65</phone>
      <email>pierreantoine-leroux@live.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 20, 2020</study_first_submitted>
  <study_first_submitted_qc>April 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2020</study_first_posted>
  <last_update_submitted>April 23, 2020</last_update_submitted>
  <last_update_submitted_qc>April 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Stress, Psychological</mesh_term>
    <mesh_term>Neurodevelopmental Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All collected data that underlie results in a publication</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will be available after the publication of result and ending fifteen years following the last visit of the last patient</ipd_time_frame>
    <ipd_access_criteria>Data access requests will be reviewed by the internal committee of Brest University Hospital. Requestors will be required to sign and complete a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

